Cytokinetics Inc. buy Barclays PLC
Start price
24.04.25
/
50%
€33.60
Target price
24.04.26
€48.44
Performance (%)
60.71%
Price
09:11
€54.00
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Cytokinetics Inc. has seen massive gains of 60.71%. This prediction currently runs until 24.04.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 3.810% | 3.810% |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $55.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€46.40
23.05.24
23.05.24
€87.72
23.05.25
23.05.25
-42.24%
24.05.25
24.05.25
